Quantifying preferences for urea cycle disorder treatments using a discrete choice experiment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Josiah,Edelblut

第一单位： Trinity Life Sciences, Waltham, MA, USA.

作者： Josiah,Edelblut ^[1] ; Jeffrey R,Skaar ^[1] ; John,Hilton ^[2] ; Matthew,Seibt ^[2] ; Kyle,Martin ^[1] ; Nandini,Hadker ^[1] ; Adrian,Quartel ^[2] ; Robert D,Steiner ^[3]

作者单位： Trinity Life Sciences, Waltham, MA, USA. ^[1] Acer Therapeutics, Newton, MA, USA, a wholly owned subsidiary of Zevra Therapeutics. ^[2] Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. ^[3]

关键词 C C3 C35 I I1 I19 adherence discrete choice experiment glycerol phenylbutyrate sodium phenylbutyrate treatment preference urea cycle disorders

主题词人类(Humans);选择行为(Choice Behavior);病人意愿(Patient Preference);投药, 口服(Administration, Oral);氮(Nitrogen)

DOI 10.1080/13696998.2024.2330846

PMID 38491962

发布时间 2024-04-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of medical economics

506-517页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Quantifying preferences for urea cycle disorder treatments using a discrete choice experiment.

Journal of medical economics

相似文献

Journal of medical economics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Quantifying preferences for urea cycle disorder treatments using a discrete choice experiment.

Journal of medical economics

相似文献

Journal of medical economics

相关期刊

检索历史清除